Highlightll Pharmaceutical
China - HangzhouPharmaceutical
Focus: Highlightll Pharmaceutical is a China-based small molecule biotech founded in 2021, focused on immunology, dermatology, and neurology indications with an early-stage clinical portfolio.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Open Jobs
0
About Highlightll Pharmaceutical
AI assessmentNot HiringNo open roles listed right now. Follow Highlightll Pharmaceutical to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
TLL018 tablet, placebo
HealthyClinical Trials (1)
NCT04243083A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study of TLL018, With Food Effect, in Healthy Participants
Phase 1Help build intelligence for Highlightll Pharmaceutical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.